Ipca Laboratories Ltd
Ipca Labs. | 524494
Stock Performance
Ratios
About Company
- Ipca Laboratories Limited (IPCA) was incorporated on 19 October, 1949 under the name of 'The Indian Pharmaceutical Combine Association Limited
- ' Ipca is a fully integrated, pharmaceutical company manufacturing and marketing over 350 formulations and 80 API's covering various therapeutic segments
- The products of the Company are now sold in over 100 countries across the globe
- The Company has 18 manufacturing units in India manufacturing API's and formulations for the world market
- Ipca's APIs and Formulations produced at world class manufacturing facilities are approved by leading drug regulatory authorities including the US-Food and Drug Administration (FDA), UK-Medicines and Healthcare products Regulatory Agency (MHRA), South Africa-Medicines Control Council (MCC), Brazil-Brazilian National Health Vigilance Agency (ANVISA) and Australia-Therapeutic Goods Administration (TGA) with operations in over 100 countries
- Ipca is one of the biggest manufacturers in the world of APIs Atenolol (Antihypertensive), Chloroquine Phosphate (Antimalarial), Furosemide (Diuretic) and Pyrantel Salts (Anthelmintic) right from the basic stage
- Ipca is also one of the largest suppliers of these APIs and their intermediates world over
- The name of the company was changed to Ipca Laboratories Limited' in 6th August of the year 1964 and again name was changed to Ipca Laboratories Private Limited' in 13th January of the year 1966
- Ipca had commissioned one of the first modern Pharma factory of yesteryears in the year 1969 at Mumbai
- The present management took over the company in November of the year 1975
Technical Indicators
Pivot Points
Volume Analysis
Growth Rate
All figures in ₹ Crores
No Information Available
No shareholding data available at this time.
News
Peers
#IndiaInvests
Trusted by 2.5 lac + Indians for their wealth-building needs
Invest in stocks with ease
Open your account in less than 10 mins*
By proceeding, you agree to all T&C *
Frequently Asked Questions
What is Share Price of Ipca Laboratories Ltd?
The current share price of Ipca Laboratories Ltd (Ipca Labs.) is ₹1464.80. This price reflects the latest market valuation and is updated in real-time during trading hours.
What is the P/E Ratio of Ipca Laboratories Ltd?
The Price-to-Earnings (P/E) ratio of Ipca Laboratories Ltd is 1464.80. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.
What is the 52-week high and low of Ipca Laboratories Ltd?
Ipca Laboratories Ltd has a 52-week high of ₹1755.90 and a 52-week low of ₹1168.20. This range shows the stock's price volatility over the past year.
What is the Dividend Yield of Ipca Laboratories Ltd?
Ipca Laboratories Ltd offers a dividend yield of 0.27%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.
What is the EPS of Ipca Laboratories Ltd?
The Earnings Per Share (EPS) of Ipca Laboratories Ltd is ₹35.26. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.
What is the ROE of Ipca Laboratories Ltd?
Ipca Laboratories Ltd has a Return on Equity (ROE) of 12.39%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.
Disclaimer:
Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.
